Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-05-14

FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a new generic combination eye drop of dorzolamide hydrochloride and timolol maleate for lowering intraocular pressure in open-angle glaucoma and oc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzolamide Hydrochloride and Timolol Maleate (Dorzolamide hydrochloride and timolol maleate)

Snippet

ORIG AP for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE)